← FDA Drug Approvals (Drugs@FDA)
ELAHERE
BLA · Biologics License Application · Sponsor: IMMUNOGEN INC · Approved 2022-11-14
Drug application
- FDA Application #
BLA761310- Application type
- Biologics License Application
- Brand name
- ELAHERE
- Generic name
- MIRVETUXIMAB SORAVTANSINE
- Active ingredients
- MIRVETUXIMAB SORAVTANSINE-GYNX
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- IMMUNOGEN INC
- Manufacturer
- ImmunoGen, Inc.
- First approval
- 2022-11-14
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown